Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
Article in Expert Opinion on Drug Safety (May 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (May 2024)
Article in Frontiers in Pharmacology (January 2024)
Article in Expert Opinion on Biological Therapy (March 2023)